Morimoto, Kozo
Gallagher, Jack R.
Wagner, Dirk
Griffith, David E.
van Ingen, Jakko
Article History
Received: 9 May 2024
Accepted: 26 June 2024
First Online: 10 July 2024
Declarations
:
: Kozo Morimoto received consultant fees from Insmed. Jack R. Gallagher is an employee of Clarity Pharma Research, LLC, Spartanburg, SC, a scientific research organization that conducted the study with funding from Insmed Incorporated, and declares no conflicts of interest. Dirk Wagner has participated in Insmed clinical trials. David E. Griffith has received consulting fees from Insmed Incorporated, AN2 Therapeutics and Paratek Pharmaceuticals. Jakko van Ingen received consultant fee from Insmed.
: This retrospective, observational study was verified as exempt from an ethical approval by Solutions IRB according to the Code of Federal Regulations under 45 CFR 46 section 101(b)(4) as the study used previously existing, anonymized, and deidentified patient data. For this type of study, informed consent is waived/not applicable.